For active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
MNEXSPIKE is approved for use in individuals who have been previously vaccinated with any COVID-19 vaccine and are:
• 65 years of age and older, or
• 12 thro
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/hYTK80a
No comments:
Post a Comment